The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
Clin. Cancer Res., Sep;15(17):5478-84 (2009)
Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-ris
Int. J. Radiat. Oncol. Biol. Phys., Mar;73(3):672-8 (2009)
Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
J. Clin. Oncol., Jul;25(21):3082-9 (2007)
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.
Int. J. Radiat. Oncol. Biol. Phys., Nov;66(3):647-53 (2006)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
Int. J. Radiat. Oncol. Biol. Phys., Apr;61(5):1285-90 (2005)
Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).
Int. J. Radiat. Oncol. Biol. Phys., Sep;42(2):263-7 (1998)
Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Cancer J Sci Am., 4(3):178-84 (1998 May-Jun)
Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma.
Int. J. Radiat. Oncol. Biol. Phys., Mar;40(4):769-82 (1998)
Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06.
Am. J. Clin. Oncol., Oct;20(5):435-40 (1997)
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
Int. J. Radiat. Oncol. Biol. Phys., Jul;38(5):911-4 (1997)
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
Prostate., Apr;31(1):42-6 (1997)
Development of anemia and recovery in prostate cancer patients treated with combined androgen blockade and radiotherapy.
Prostate., Oct;29(4):243-8 (1996)
Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
Cancer Res., Jun;56(12):2827-31 (1996)
Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer.
Cancer., May;77(9):1905-11 (1996)
Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group.
Am. J. Clin. Oncol., Apr;19(2):114-20 (1996)
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
Int. J. Radiat. Oncol. Biol. Phys., Jun;32(3):577-88 (1995)
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
Cancer., Nov;74(10):2828-35 (1994)
Treatment related sequelae following external beam radiation for prostate cancer: a review with an update in patients with stages T1 and T2 tumor.
J. Urol., Nov;152(5 Pt 2):1799-805 (1994)
PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation.
Int. J. Radiat. Oncol. Biol. Phys., Sep;30(2):289-92 (1994)
Patterns of Care and RTOG studies in prostate cancer: long-term survival, hazard rate observations, and possibilities of cure.
Int. J. Radiat. Oncol. Biol. Phys., Jan;28(1):39-45 (1994)
Evaluation of 45 degrees C hyperthermia and irradiation. II. A phase I clinical trial in humans by the Radiation Therapy Oncology Group.
Am. J. Clin. Oncol., Dec;16(6):477-81 (1993)
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.
Lung Cancer., Dec;10(3-4):189-97 (1993)
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Int. J. Radiat. Oncol. Biol. Phys., May;26(2):239-44 (1993)
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
J. Natl. Cancer Inst., May;85(9):704-10 (1993)
CT characteristics of patients with brain metastases treated in RTOG study 79-16.
Int. J. Radiat. Oncol. Biol. Phys., Jan;25(2):209-14 (1993)
Effects of hyperthermia on bone. II. Heating of bone in vivo and stimulation of bone growth.
Int J Hyperthermia., 9(1):77-87 (1993 Jan-Feb)
Effects of hyperthermia on bone. I. Heating rate patterns induced by microwave irradiation in bone and muscle phantoms.
Int J Hyperthermia., 9(1):69-75 (1993 Jan-Feb)
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
J. Neurooncol., Mar;12(3):219-27 (1992)
Comparison of pathologic and clinical evaluation of lymph nodes in prostate cancer: implications of RTOG data for patient management and trial design and stratification.
Int. J. Radiat. Oncol. Biol. Phys., 23(2):293-8 (1992)
Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.
Int. J. Radiat. Oncol. Biol. Phys., Sep;21(4):935-9 (1991)
The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience.
Int. J. Radiat. Oncol. Biol. Phys., Sep;21(4):925-33 (1991)
Biopsies of non-small cell lung cancer: central review in cooperative studies of the Radiation Therapy Oncology Group.
Mod. Pathol., Jul;4(4):432-5 (1991)
Prognostic factors in unresectable hepatocellular cancer: Radiation Therapy Oncology Group Study 83-01.
Int. J. Radiat. Oncol. Biol. Phys., Jan;20(1):65-71 (1991)
Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies.
Int. J. Radiat. Oncol. Biol. Phys., Mar;18(3):523-8 (1990)
Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for A2 and B prostate carcinoma.
Int. J. Radiat. Oncol. Biol. Phys., Nov;17(5):945-51 (1989)
Variation of lung density corrections in a typical patient population.
Med Dosim., Sep;14(3):179-84 (1989)
Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Cancer., Feb;63(3):461-6 (1989)
Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06.
Int. J. Radiat. Oncol. Biol. Phys., Dec;15(6):1307-16 (1988)
Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06.
Int. J. Radiat. Oncol. Biol. Phys., Jul;13(7):1007-12 (1987)
Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues.
Urology., Jul;30(1):18-21 (1987)
Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview.
Int. J. Radiat. Oncol. Biol. Phys., May;13(5):659-63 (1987)
Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.
Cancer., Jul;58(1):29-36 (1986)
Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate.
Int. J. Radiat. Oncol. Biol. Phys., Oct;10(10):1861-7 (1984)
Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
Prostate., 5(5):471-6 (1984)
Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate.
Am. J. Clin. Oncol., Aug;6(4):485-91 (1983)
Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
Int. J. Radiat. Oncol. Biol. Phys., 8(3-4):357-9 (1982 Mar-Apr)
J Med Educ., Jan;57(1):78 (1982)
CT scanning in the male genital tract and in recurrent rectal carcinoma: a review.
J Comput Tomogr., Aug;5(3):244-55 (1981)
Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
Cancer Clin Trials., 4(3):285-93 (1981)
Malignant lymphoma of the gastrointestinal tract. Erskine Memorial Lecture, 1979.
Radiology., Nov;137(2):291-8 (1980)
Revision of treatment planning for carcinoma of the prostate.
Int. J. Radiat. Oncol. Biol. Phys., Jul;6(7):861-5 (1980)
Individualized eye shields for use in electron beam therapy as well as low-energy photon irradiation.
Int. J. Radiat. Oncol. Biol. Phys., Apr;6(4):519-21 (1980)
The use of computerized tomography scanning in treatment planning for bladder carcinoma.
Int. J. Radiat. Oncol. Biol. Phys., Jan;5(1):99-103 (1979)
Subtotal mastectomy and radiation therapy in the definitive management of localized breast malignancy.
AJR Am J Roentgenol., Sep;127(3):505-7 (1976)
Effect of acute and fractionated partial body x-irradiation on circulating immunoglobulin levels in mice.
Int. J. Radiat. Oncol. Biol. Phys., 1(5-6):465-70 (1976 Mar-Apr)
Preoperative radiation therapy. A plan for combined therapy by the Radiation Therapy Oncology Group and the Central Oncology Group.
Cancer., Sep;34(3):suppl:960-4 (1974)
Evolution of radiotherapeutic techniques.
Gynecol. Oncol., Aug;2(2-3):314-23 (1974)
Oxygen effect on the production of radiation-induced myelitis in rats.
Radiology., Mar;98(3):678-81 (1971)
The use of thermography in the detection of metastatic liver disease.
Radiology., Jun;95(3):696-8 (1970)